<DOC>
	<DOCNO>NCT01422135</DOCNO>
	<brief_summary>This pharmacokinetics safety study 3 weekly application .</brief_summary>
	<brief_title>Pharmacokinetic Study AG200-15 Transdermal Patch Three Anatomical Sites Healthy Females</brief_title>
	<detailed_description>Pharmacokinetic study evaluate safety pharmacokinetic profile AG200-15 follow application three different anatomical site ( abdomen , buttock upper torso ) .</detailed_description>
	<criteria>Healthy woman , age 1845 year Body mass index 18 32 , weight â‰¥ 110 lb . Willing use nonhormonal method contraception childbearing potential , Or already undergone previous bilateral tubal ligation hysterectomy Willing refrain use alcohol grapefruit juice 48 hour prior patch application completion treatment period Willing give inform consent participate study Hemoglobin within normal range .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>PK safety</keyword>
	<keyword>Pharmacokinetic profile ( PK ) safety</keyword>
</DOC>